Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up

被引:0
|
作者
M Isaac
N Tehrani
K Mireskandari
机构
[1] The Hospital for Sick Children,Department of Ophthalmology and Vision Sciences
[2] University of Toronto,Department of Ophthalmology and Vision Sciences
来源
Eye | 2016年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:333 / 341
页数:8
相关论文
共 50 条
  • [1] Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up
    Isaac, M.
    Tehrani, N.
    Mireskandari, K.
    EYE, 2016, 30 (03) : 334 - 340
  • [2] Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
    Chang, Yu-Shan
    Chen, Ying-Tin
    Lai, Tso-Ting
    Chou, Hung-Chieh
    Chen, Chien-Yi
    Hsieh, Wu-Shiun
    Yang, Chung-May
    Yeh, Po-Ting
    Tsao, Po-Nien
    PLOS ONE, 2019, 14 (10):
  • [3] Intravitreal bevacizumab as treatment for retinopathy of prematurity
    Bancalari M, Aldo
    Schade Y, Ricardo
    Pena Z, Ruben
    Pavez P, Nicolas
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2013, 84 (03): : 300 - 307
  • [4] Retrospective cost-benefit analysis of retinopathy of prematurity (ROP) screening, follow-up, and treatment with intravitreal bevacizumab
    Guevara, Jade Gieseke Gieseke
    Amin, Sarina Mahesh
    Agarwal, Swati
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [5] Prolonged follow-up period following intravitreal bevacizumab injection for stage 3+retinopathy of prematurity
    de Klerk, T. A.
    Park, D. Y.
    Biswas, S.
    EYE, 2013, 27 (10) : 1218 - 1218
  • [6] Prolonged follow-up period following intravitreal bevacizumab injection for stage 3+ retinopathy of prematurity
    T A de Klerk
    D Y Park
    S Biswas
    Eye, 2013, 27 : 1218 - 1218
  • [7] Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity
    Law, Janice C.
    Recchia, Franco M.
    Morrison, David G.
    Donahue, Sean P.
    Estes, Robert L.
    JOURNAL OF AAPOS, 2010, 14 (01): : 6 - 10
  • [8] Intravitreal Bevacizumab for Retinopathy of Prematurity
    Harder, Bjoern C.
    von Baltz, Stefan
    Jonas, Jost B.
    Schlichtenbrede, Frank C.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (06) : 623 - 627
  • [9] Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
    Ji, Marco H.
    Callaway, Natalia F.
    Greven, Margaret A.
    Vail, Daniel
    Moshfeghi, Darius M.
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 1161 - 1163
  • [10] Bevacizumab for Retinopathy of Prematurity: 2-Year Neurodevelopmental Follow-up
    Zayek, Michael
    Parker, Kaitlyn
    Rydzewska, Monika
    Rifai, Aref
    Bhat, Ramachandra
    Eyal, Fabien
    AMERICAN JOURNAL OF PERINATOLOGY, 2021, 38 (11) : 1158 - 1166